guanfacine has been researched along with Hypercapnia in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, K | 1 |
| Asanoi, H | 1 |
| Ueno, H | 1 |
| Joho, S | 1 |
| Takagawa, J | 1 |
| Kameyama, T | 1 |
| Hirai, T | 1 |
| Nozawa, T | 1 |
| Inoue, H | 1 |
1 other study available for guanfacine and Hypercapnia
| Article | Year |
|---|---|
Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure.
Topics: Carbon Dioxide; Dyspnea; Exercise; Exercise Test; Exercise Tolerance; Female; Guanfacine; Heart Fail | 2004 |